SOLASTA® Bio Expands Patent Portfolio and Reports Strong Global Field Trial Results
SOLASTA® Bio now holds 14 granted patents for its peptide-based bioinsecticides, including eight in the U.S. and six in Europe.
SOLASTA® Bio now holds 14 granted patents for its peptide-based bioinsecticides, including eight in the U.S. and six in Europe.
To provide the best experience, we use technologies like cookies to store and access device information.
Funding rounds, partnerships, product launches, and market moves across the global AgTech landscape — delivered every Friday. No noise.